Malacoplakia is an unusual chronic granulomatous infl ammation that commonly occurs in the urinary tract. It is rarely encountered in the head and neck region, and only a handful of such cases have been described. We report a case of malacoplakia in a 50-year-old woman who presented with a mass in the vallecula that was clinically suspected of being malignant. Th is case illustrates the importance of recognizing this unusual benign lesion, which closely mimics a malignancy on clinical examination.
Introduction
Malacoplakia is an uncommon, distinctive type of chronic infl ammatory disorder of obscure etiology. It was fi rst described by Michaelis and Gutmann in 1902. 1 It is characterized by the presence of sheets of histiocytes with granular cytoplasm (von Hansemann cells) admixed with intracellular and extracellular basophilic laminated inclusions (Michaelis-Gutmann bodies). Th is disorder most commonly involves the genitourinary tract; the head and neck region is a rather uncommon site of this disease process. Reports of head and neck involvement have included the larynx, 2 palatine tonsil, [3] [4] [5] middle ear, 6 tongue, 7 parotid gland, 8 temporal bone, 9 neck, 10 nasopharynx, 11, 12 oropharynx, 13, 14 and submental region. 14 We report an unusual case of malacoplakia that occurred in the vallecula.
Case report
A 50-year-old woman presented to our ENT outpatient department with a 3-month history of pain and irritation in her throat without any associated constitutional symptoms. Local examination detected a whitish, pedunculated, 1 × 1-cm mass in the left vallecula. Th e regional lymph nodes were not enlarged, and clinical examination of the upper aerodigestive tract did not reveal any abnormality. Th e lesion was clinically suspected to be malignant, and a biopsy was performed. Th e tissue was fi xed in 10% formalin and routinely processed. Sections of 5 μm were cut for hematoxylin and eosin staining and for special staining.
Microscopic examination of the tissue showed sheets of histiocytes with abundant granular eosinophilic cytoplasm and rounded regular central nuclei admixed with a variable population of lymphocytes and plasma cells. Small, round to oval targetoid structures that were morphologically consistent with Michaelis-Gutmann bodies were seen within the cytoplasm of many of these histiocytes, as well as lying extracellularly (fi gure, A and B). Th ese bodies reacted on periodic acid-Schiff staining with and without diastase (fi gure, C), on von Kossa staining for calcium, and on Prussian blue staining for iron (fi gure, D). Based on these features, the diagnosis of malacoplakia was entertained.
Th e patient was treated with oral ciprofl oxacin at 500 mg twice a day for 2 weeks and closely followed up. At the last follow-up 6 months aft er the initial presentation, she was asymptomatic, and local examination revealed a complete resolution of the lesion.
Discussion
Th e present case illustrates the diffi culty in clinically recognizing malacoplakia when it occurs outside the lower urinary tract. In that location, it manifests in its classic presentation as a soft , elevated mucosal plaque that bespeaks its etymology (from the Greek malacos, "soft , " and placos, "plaque"). But its appearance is highly variable at other sites, where it can mimic malignancy chronic infl ammatory response and evolves into classic malacoplakia over time. Colby reported a unique case of retroperitoneal malacoplakia in which early biopsies showed acute infl ammation, necrosis, and granulation tissue, while later biopsies revealed a reduction in the number of acute infl ammatory cells and an increase in the number of macrophages and lymphocytes. 17 Kalfayan and Seagar reported a case of malacoplakia in the tonsil in which pretreatment biopsies demonstrated the classic features of malacoplakia (i.e., von Hansemann cells and Michaelis-Gutmann bodies), while a post-treatment biopsy exhibited noteworthy histologic changes that were characterized by the disappearance of edema, granulocytes, and bacilli and a striking increase in the population of Michaelis-Gutmann bodies before eventual resolution of the lesion. 3 Th e etiology of malacoplakia remains largely obscure. Because the disease demonstrates similar morphologic features irrespective of the site of involvement, it is likely that its pathogenesis is the same in all organs. Th e currently held view is that malacoplakia arises as a consequence of an impairment in the ability of phagocytes to completely digest bacteria. 18 Fragments of incompletely digested bacteria form an organic by presenting as a mass lesion. In the present case, a clinical diagnosis of carcinoma was initially entertained in view of the fact that the vallecula is a common site for oropharyngeal malignancies.
Various reports of head and neck malacoplakia that masqueraded as a malignant neoplasm have been described. Douglas-Jones et al reported a case of malacoplakia in a patient who presented with a short history of a large, rapidly growing soft -tissue mass in the neck. 10 Salins and Trivedi reported a case of extensive malacoplakia of the nasopharynx that extended into the paranasal sinuses and skull base with considerable bony destruction. 11 Coombes et al reported another case of malacoplakia that masqueraded as a malignancy by presenting as a fungating mass in the periauricular region. 15 Th e diagnosis of malacoplakia is based on its histologic features, which are uniformly consistent irrespective of the site of involvement. Th e histologic hallmark of the disease is the presence of large granular macrophages (von Hansemann cells) that contain laminated, calcifi ed structures (Michaelis-Gutmann bodies). 2, 3 However, microscopic features may be variable, and typical von Hansemann cells and Michaelis-Gutmann bodies are not always conspicuous. Smith postulated that the lesions of malacoplakia evolve through three histologic phases: (1) an early prediagnostic phase, which is characterized by the presence of an infi ltrate of plasma cells, von Hansemann macrophages, and eosinophils and an absence of Michaelis-Gutmann bodies; (2) a classic phase, which is characterized by the presence of sheets of large macrophages that contain Michaelis-Gutmann bodies along with lymphocytes and plasma cells; and (3) a fi brosing phase, which is characterized by islands of macrophages with Michaelis-Gutmann bodies set in a fi brous stroma. 16 It is increasingly being appreciated that there exists a spectrum of histologic changes that begins as an acute or
Figure. A: Photomicrograph shows sheets of large histiocytes with eosinophilic granular cytoplasm and an extracellular Michaelis-Gutmann body (arrow) (H&E, original magnifi cation ×100). B: Higher magnifi cation shows the histiocytes and an extracellular Michaelis-Gutmann body (arrow) (H&E, original magnifi cation ×200). C: Stain for the periodic acid-Schiff reaction highlights Michaelis-Gutmann bodies (arrows) (original magnifi cation ×200). D: A Michaelis-Gutmann body (arrow) is also highlighted on Prussian blue staining for iron (original magnifi cation ×200).
matrix that harbors the cytoplasmic deposition of calcium and other inorganic salts, which in turn form a Michaelis-Gutmann body. Th e phagocytes' inability to digest microorganisms is thought to be related to low levels of intracellular cyclic guanosine monophosphate (cGMP) and a diminished release of beta-glucuronidase. Diminished intracellular cGMP is believed to interfere with adequate microtubular function and lysosomal activity, leading to the incomplete elimination of bacteria from macrophages and monocytes. 18, 19 Th is would explain the successful treatment of a case by Stanton et al, who used the cholinergic agonist bethanechol, which acts by increasing the levels of cGMP. 20 Th e frequent association of bladder malacoplakia with urinary tract infection suggests an infectious etiologic agent. Coliform bacteria, particularly Escherichia coli, have been isolated in involved sites of genitourinary malacoplakia in more than two-thirds of patients. 21 Less frequently, various other micro-organisms, including Rhodococcus equi and Proteus and Klebsiella species, have been found to be associated with malacoplakia. 21 Another factor that has been implicated in the pathogenesis of malacoplakia is an abnormal or altered immune response. A higher incidence of malacoplakia has been seen in patients who are immunosuppressed or who have a debilitating disease. 21 However, our patient did not have any history suggestive of an immune defi ciency or other chronic illness. Th erefore, we believe that the pathogenesis of malacoplakia probably involves interactions among multiple factors.
Th e treatment options for malacoplakia include antibiotics, surgical excision, or both, depending on the site and extent of involvement. Antibiotics that can penetrate cell membranes and concentrate in macrophages are associated with high cure rates. Ciprofl oxacin has been found to be particularly useful in this regard, 22 as it was in our patient. Likewise, results with a cholinergic agonist such as bethanechol in combination with antibiotics have been encouraging. 20 Although localized lesions might respond to medical therapy, surgical intervention is required when the involvement is more extensive.
